What's breaking now, across thousands of outlets.
(MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the investigational once-weekly nanobody gefurulimab significantly...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
(MedPage Today) -- ORLANDO -- Rheumatoid arthritis (RA) may not be as amenable to chimeric antigen receptor (CAR) T-cell therapy as has been the case in lupus and certain other autoimmune conditions…
Beam Therapeutics announced Tuesday that its base-edited sickle cell therapy succeeded in a clinical trial, meaning a third one-time therapy for the disease may soon enter the market.
Premature death risk also varies according to employment and qualifications, shows analysis ‘laying bare the scale of inequalities’ People living in the most deprived areas of England are more than…
An international panel of scientific experts will convene on Tuesday to evaluate the status, but genetic data already shows the virus is once again endemic in the United States.
Nigeria’s Health Minister, Muhammad Pate, reports a 60% drop in maternal deaths in areas under the FG’s MAMII initiative, citing improved healthcare access Read More…
A rare eye disease has been added to the growing list of side effects linked to GLP-1s, adding a second eye warning to several labels.
